Aarkstore - Vasculitis - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Vasculitis - Pipeline Review, H2 2014 PowerPoint presentation | free to download - id: 72d764-ZmFhO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Vasculitis - Pipeline Review, H2 2014

Description:

Vasculitis - Pipeline Review, H2 2014 report reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. Browse full report @ – PowerPoint PPT presentation

Number of Views:14

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Vasculitis - Pipeline Review, H2 2014


1
Vasculitis - Pipeline Review, H2 2014
Healthcare Market Research Report
2
Summary
  • Vasculitis - Pipeline Review, H2 2014, provides
    an overview of the Vasculitiss therapeutic
    pipeline.
  • This report provides comprehensive information
    on the therapeutic development for Vasculitis,
    complete with comparative analysis at various
    stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
    administration (RoA) and molecule type, along
    with latest updates, and featured news and press
    releases. It also reviews key players involved in
    the therapeutic development for Vasculitis and
    special features on late-stage and discontinued
    projects.
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.

3
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Vasculitis- The report
    reviews key pipeline products under drug profile
    section which includes, product description, MoA
    and RD brief, licensing and collaboration
    details other developmental activities - The
    report reviews key players involved in the
    therapeutics development for Vasculitis and
    enlists all their major and minor projects- The
    report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Vasculitis products under development by
    companies and universities/research institutes
    based on information derived from company and
    industry-specific sources- Pipeline products
    coverage based on various stages of development
    ranging from pre-registration till discovery and
    undisclosed stages
  • Browse full report or Sample Request _at_
  • http//www.aarkstore.com/healthcare/89757/vasculit
    is-pipeline-review-h2-2014

4
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Vasculitis- Plan mergers and
    acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Vasculitis pipeline depth and focus
    of Indication therapeutics- Develop and design
    in-licensing and out-licensing strategies by
    identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and Scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

5
Table of Content
  • Introduction 7Global Markets Direct Report
    Coverage 7Vasculitis Overview 8Therapeutics
    Development 9Pipeline Products for Vasculitis -
    Overview 9Pipeline Products for Vasculitis -
    Comparative Analysis 10Vasculitis - Therapeutics
    under Development by Companies 11Vasculitis -
    Pipeline Products Glance 13Late Stage Products
    13Clinical Stage Products 14Early Stage
    Products 15Vasculitis - Products under
    Development by Companies 16Vasculitis -
    Companies Involved in Therapeutics Development
    17AnGes MG, Inc. 17Anthera Pharmaceuticals Inc.
    18Aprogen, Inc. 19ChemoCentryx, Inc. 20

6
List of Tables
  • Number of Products under Development for
    Vasculitis, H2 2014 9Number of Products under
    Development for Vasculitis - Comparative
    Analysis, H2 2014 10Number of Products under
    Development by Companies, H2 2014 11Comparative
    Analysis by Late Stage Development, H2 2014
    13Comparative Analysis by Clinical Stage
    Development, H2 2014 14Comparative Analysis by
    Early Stage Development, H2 2014 15Products
    under Development by Companies, H2 2014
    16Vasculitis - Pipeline by AnGes MG, Inc., H2
    2014 17Vasculitis - Pipeline by Anthera
    Pharmaceuticals Inc., H2 2014 18Vasculitis -
    Pipeline by Aprogen, Inc., H2 2014 19Vasculitis
    - Pipeline by ChemoCentryx, Inc., H2 2014
    20Vasculitis - Pipeline by Clearside BioMedical,
    Inc., H2 2014 21Vasculitis - Pipeline by Epirus
    Biopharmaceuticals, Inc., H2 2014 22Vasculitis -
    Pipeline by F. Hoffmann-La Roche Ltd., H2 2014
    23Vasculitis - Pipeline by GlaxoSmithKline plc,
    H2 2014 24Vasculitis - Pipeline by Hemostemix
    Ltd, H2 2014 25

7
List of Figures
  • Number of Products under Development for
    Vasculitis, H2 2014 9Number of Products under
    Development for Vasculitis - Comparative
    Analysis, H2 2014 10Number of Products under
    Development by Companies, H2 2014 11Comparative
    Analysis by Clinical Stage Development, H2 2014
    14Comparative Analysis by Early Stage Products,
    H2 2014 15Assessment by Monotherapy Products, H2
    2014 32Number of Products by Top 10 Targets, H2
    2014 33Number of Products by Stage and Top 10
    Targets, H2 2014 33Number of Products by Top 10
    Mechanism of Actions, H2 2014 35Number of
    Products by Stage and Top 10 Mechanism of
    Actions, H2 2014 35Number of Products by Top 10
    Routes of Administration, H2 2014 37Number of
    Products by Stage and Top 10 Routes of
    Administration, H2 2014 37Number of Products by
    Top 10 Molecule Types, H2 2014 39Number of
    Products by Stage and Top 10 Molecule Types, H2
    2014 39

8
Related Reports
  • United States OffLabel Drugs Market Forecast
  • Canada Pediatric Vaccines Market, Doses,
    Immunization (Vaccinated), Cases Forecast
  • Intrauterine Contraceptive Devices Market
    (IUD/IUCD),by Type Hormonal IUCD, Copper IUCD
    Global Forecast to 2019
  • Asian Healthcare Workflow Systems Market by Type
    (Fraud Detection, Pharmacy Audit Analysis,
    Claim Management System, Customer Relationship
    Management), by End-User - Forecast to 2019
  • Healthcare IT (HIT) Market in the APAC Region
    2015-2019
  • Complete 2015-16 Induced Pluripotent Stem Cell
    (iPSC) Industry Report
  • Global Healthcare BPO Market 2015-2019

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
About PowerShow.com